Greg Silvesti
Head of Digital Health & Innovation


As Head of Digital Health & Innovation in the Development Design Center at AbbVie, Greg is establishing the vision for digital health for AbbVie’s development organization and developing the strategy for how the company can reinvent clinical trials and product development by leveraging digital, enabling technologies. Prior to joining AbbVie, Greg led a global team at Teva Pharmaceuticals that was focused on Digital Health and leveraging human-centric research approaches and the latest digital platforms including IoT devices, next-generation wearables, zero UI, and 3D printed offerings to develop “beyond the pill” solutions and combination products for customers. Greg came to Teva from Bristol-Myers Squibb, where he led a Worldwide Customer Insights and Innovation team, focused on disruptive business opportunities around evolving patient-centric and novel healthcare delivery models.

Prior to joining Bristol-Myers Squibb, Greg worked for Johnson & Johnson, as part of its Diabetes Care Division, helping develop the OneTouch Verio Platform, as well as the company’s first blue-tooth enabled smart Blood Glucose Meter and companion app, which was selected by Apple as a “Top Pick” for diabetes management.